Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v5-FR Version v1-EN
Language French English
Date Updated 2019-09-04 2019-07-12
Drug Identification Number 02466821 02466821
Brand name ALMOTRIPTAN ALMOTRIPTAN
Common or Proper name ALMOTRIPTAN ALMOTRIPTAN
Company Name SANIS HEALTH INC SANIS HEALTH INC
Ingredients ALMOTRIPTAN ALMOTRIPTAN
Strength(s) 12.5MG 12.5MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL
Packaging size 6 6
ATC code N02CC N02CC
ATC description ANTIMIGRAINE PREPARATIONS ANTIMIGRAINE PREPARATIONS
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2019-07-12 2019-07-12
Estimated end date 2019-09-18 2019-08-30
Actual end date
Shortage status Actual shortage Anticipated shortage
Tier 3 Status No No
Company comments
Health Canada comments